We are live on
!
Find out more
CYTH
Cyclo Therapeutics, Inc. Common Stock
CYTH
CYTH
Delisted
CYTH was delisted on the 25th of March, 2025.
16 hedge funds and large institutions have $820K invested in Cyclo Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
7% more funds holding
Funds holding: 15 → 16 (+1)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
55% less capital invested
Capital invested by funds: $1.83M → $820K (-$1.01M)
Holders
16
Holders Change
+1
Holders Change %
+6.67%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$26.3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.2K |
| 3 |
SSG
Summit Securities Group
New York
|
+$2.45K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$427 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$14 |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$465K |
| 2 |
LPL Financial
San Diego,
California
|
-$14.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.66K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$26 |
